Adverse effects of anti-tuberculosis drugs in hemodialysis patients

Conclusions: Most of hemodialysis patients with newly diagnosed tuberculosis received complete scheme of anti-tuberculosis treatment (77.8%). The first-line TB drugs were oftener used (57.1%). The most adverse effects were neurotoxicity (26.9%) and hepatotoxicity (15.4%). TB treatment was cancelled due to Pt –50%, R – 37.5%, and Z – 37. 5%. Mfx, Spx, Cs, Ter, Pas, Lzd, Bq were used less often, but demonstrated higher safety.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Gordeeva, O., Karpina, N., Vedernikova, R., Schultz, I., Bagdasarian, A. Tags: Tuberculosis Source Type: research